Skip to main content
. 2020 May 12;41(5):733–755. doi: 10.1210/endrev/bnaa015

Table 2.

Time-action of intermediate-acting and long-acting insulins (100 U/mL).

Insulin Type Brand name Onset of Action (hr)a Peak Action (hr) Duration of Action (hr)
Intermediate-acting U-100
 NPH insulin Humulin® N (40), Novolin® N (41) 1–2 2–8 14–24
Long-acting U-100
 Insulin glargine Lantus® (43), Basaglar® NA No pronounced peak 24
 Insulin detemir Levemir® (52) NA No pronounced peak 7.6–>24
 Insulin degludec Tresiba® (59) NA No pronounced peak 42

a The onset of action is not relevant for long-acting insulins.